依达拉奉治疗缺血性脑卒中106例疗效分析  

Curative Effect Observation of 106 cases with Edaravone for Treating Cerebral Ischemic Stroke

作　　者：祁俐[1] 何志义[1] 

机构地区：[1]中国医科大学,辽宁沈阳110000

出　　处：《大家健康（学术版）》2012年第2期1-2,共2页

摘　　要：目的分析探讨依达拉奉治疗急性缺血性脑卒中的临床疗效及安全性。方法将106例急性缺血性脑卒中患者随机分成治疗组和对照组各53例,治疗组在常规治疗基础上加用依达拉奉治疗,对照组在常规治疗基础上用血塞通治疗,14d后进行疗效评定。结果治疗组总有效率为90.58%,对照组总有效率为75.47%,两组比较差异有统计学意义(P<0.05)。治疗组及对照组神经功能缺损程度评分与治疗前相比均有显著改善(P<0.05);治疗组治疗后神经功能缺损程度评分显著低于对照组,两组比较差异有统计学意义(P<0.05)。结论依达拉奉可有效的改善急性脑卒中患者的神经功能缺失,治疗急性缺血性脑卒中的疗效肯定,且不良反应少,值得推广应用。Objective To approach the curative effect and clinical safety of edaravone for treating cerebral ischemic stroke.Methods 106 patients with cerebral ischemic stroke were randomly divided into edaravone group(treatment group) and control group,53 cases in each group.Patients in treatment group received added edaravone therapy on the basis of internal conventional therapy,patients in control group received internal conventional therapy added sanqi panax notoginseng therapy.Curative effect evaluations were carried out 14 days after treatment in both groups.Results The total effective rate of treatment group was 90.58%,which was significantly higher than control group(75.47,P<0.05).The neurological deficit score after treatment in treatment group was significantly lower than in control group(P<0.05).Conclusion Edaravone can improve neurological deficit of patients with cerebral ischemic stroke,has definite curative effect for treating cerebral ischemic stroke.

关 键 词：脑卒中 依达拉奉 药物疗法 治疗结果 

分 类 号：R743.3[医药卫生—神经病学与精神病学]